Vir Biotechnology, Inc.
VIR
$10.87
-$0.31-2.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2,159.85% | 263.73% | -14.04% | -85.85% | -83.18% |
| Total Other Revenue | -40.86% | 16.88% | 189.50% | -- | -- |
| Total Revenue | 1,495.93% | 213.96% | -7.61% | -78.55% | -75.91% |
| Cost of Revenue | -5.51% | -14.15% | -9.33% | -7.08% | 12.78% |
| Gross Profit | 63.23% | 23.66% | 9.63% | -6.09% | -31.37% |
| SG&A Expenses | 0.72% | -14.24% | -22.65% | -28.75% | -33.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.51% | -14.16% | -11.88% | -11.61% | 1.34% |
| Operating Income | 52.59% | 22.01% | 12.46% | 2.21% | -12.95% |
| Income Before Tax | 54.31% | 23.61% | 16.31% | 7.38% | -11.72% |
| Income Tax Expenses | 37.18% | 126.41% | 118.95% | 104.59% | 103.00% |
| Earnings from Continuing Operations | 54.26% | 23.36% | 16.09% | 6.32% | -13.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.26% | 23.36% | 16.09% | 6.32% | -13.91% |
| EBIT | 52.59% | 22.01% | 12.46% | 2.21% | -12.95% |
| EBITDA | 53.62% | 22.27% | 12.26% | 1.46% | -14.64% |
| EPS Basic | 53.66% | 25.74% | 17.32% | 7.74% | -12.10% |
| Normalized Basic EPS | 53.15% | 22.14% | 9.37% | -1.89% | -19.63% |
| EPS Diluted | 53.47% | 25.74% | 17.32% | 7.84% | -11.97% |
| Normalized Diluted EPS | 53.06% | 22.14% | 9.37% | -1.89% | -19.63% |
| Average Basic Shares Outstanding | 7.98% | 3.07% | 1.67% | 1.64% | 1.66% |
| Average Diluted Shares Outstanding | 8.19% | 3.07% | 1.67% | 1.64% | 1.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |